Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Percent change from baseline in total number of treated mild lesions per side at week 12.
At baseline, mild lesions will be mapped on each side. At week 12 each mild lesion response will be assessed per side as: Complete response (Complete disappearance of the lesion, visually and by palpation) Non-complete response (Non-complete disappearance of the lesion) At week 12, the percent change from baseline in number of treated mild lesions per side will be calculated.
Baseline and week 12
St George Dermatology and skin Cancer Center
Australia: Department of Health and Ageing Therapeutic Goods Administration